Before you sell to, join or invest in Avenue Biosciences Holding Inc
MentionFox check on Avenue Biosciences Holding Inc: only 1 source on file so far (checked 7 November 2026). Run a full check before you rely on it. mentionfox.com/c/funding/avenue-biosciences-holding-inc-form-d-26000001
Check Avenue Biosciences Holding Inc before you sell to, join or invest Free, no sign-up: every record on file, each linked to its source.
What do you want to do about Avenue Biosciences Holding Inc?
Avenue Biosciences Holding Inc filed a Form D with the Securities and Exchange Commission on 2026-01-28.
Avenue Biosciences Holding Inc filed a Form D notice of an exempt securities offering with the SEC on January 28, 2026. The filing reports $7.44M sold. Its industry group is Biotechnology. It names Tero-Pekka Alastalo (Executive Officer, Director), Katja Rosti (Executive Officer, Director), Gabriel Poteliunaite (Director) (SEC Form D, January 28, 2026).
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like Avenue Biosciences Holding Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-01-28 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Avenue Biosciences Holding Inc.
Free to see. No signup.
More on the people and the money behind Avenue Biosciences Holding Inc, from the filings we hold.
Biotechnology raises by companies based in California, filed in January 2026, largest first.
Get an email when Avenue Biosciences Holding Inc files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Avenue Biosciences Holding Inc raises, hires or launches. No email unless you switch it on.
Watch Avenue Biosciences Holding Inc →Get the full cited report on Avenue Biosciences Holding Inc
What the filing shows about Avenue Biosciences Holding Inc
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Avenue Biosciences Holding Inc: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Avenue Biosciences Holding Inc's address as 211 Laurel Street, Menlo Park, CA 94025.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Avenue Biosciences Holding Inc See pricing
Avenue Biosciences Holding Inc is a registered filer with the SEC (CIK 2101752) and has filed since 2026-01-28. 1 filing is on record, the latest on 2026-01-28.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Avenue Biosciences Holding Inc's Form D of 2026-01-28 names Tero-Pekka Alastalo, Katja Rosti, Gabriel Poteliunaite and 1 more as its officers, directors or promoters.
Its new offerings report $7.44M sold across 1 offering, as its own filings state.
Trailing twelve months. 763 filings in Biotechnology, totalled by week. The dot is this raise, $7.44M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Tero-Pekka Alastalo is named as Executive Officer and Director on the Form D that Avenue Biosciences Holding Inc filed with the SEC on 28 January 2026, one of 4 people that filing names.
Katja Rosti is named as Executive Officer and Director on the Form D that Avenue Biosciences Holding Inc filed with the SEC on 28 January 2026, one of 4 people that filing names.
Gabriel Poteliunaite is named as Director on the Form D that Avenue Biosciences Holding Inc filed with the SEC on 28 January 2026, one of 4 people that filing names.
Jenny Engerfelt is named as Director on the Form D that Avenue Biosciences Holding Inc filed with the SEC on 28 January 2026, one of 4 people that filing names.
4 people named on the filing — 2 holding an executive role and 2 as directors only.
Named as of the 2026-01-28 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about Avenue Biosciences Holding Inc
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Avenue Biosciences Holding Inc: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Avenue Biosciences Holding Inc covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Avenue Biosciences Holding IncYou get an alert in MentionFox the next time this company shows up.
If you're behind Avenue Biosciences Holding Inc: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Avenue Biosciences Holding Inc. With no account yet, you sign up free and land on the result.
On these lists: Biotech raises in San Francisco Bay Area
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/avenue-biosciences-holding-inc-form-d-26000001